BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4321423)

  • 21. Unspecific metabolic blood parameters as used in clinical routine may differentiate malignant from benign cerebral tumors.
    Stover JF; Hopf NJ; Perneczky A; Kempski OS
    Cancer Lett; 1995 Aug; 95(1-2):147-52. PubMed ID: 7656223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permeability in brain tumors.
    Tator CH; Schwartz ML
    J Neurosurg; 1971 Mar; 34(3):460-2. PubMed ID: 5547331
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of tumor proliferation marker ki-67 and PCNA in surgical pathology].
    Su J; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):568-71. PubMed ID: 20021977
    [No Abstract]   [Full Text] [Related]  

  • 24. Production of prostaglandins and thromboxane by isolated cells from intracranial tumours.
    Cooper C; Jones HG; Weller RO; Walker V
    J Neurol Neurosurg Psychiatry; 1984 Jun; 47(6):579-84. PubMed ID: 6330309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 protein overexpression in astrocytic neoplasms.
    Cho MY; Jung SH; Kim TS
    Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperprolactinaemia and prolactin binding in benign intracranial tumours.
    Ciccarelli E; Razzore P; Gaia D; Todaro C; Longo A; Forni M; Ghè C; Camanni F; Muccioli G; Faccani G; Lanotte MM
    J Neurosurg Sci; 2001 Jun; 45(2):70-4. PubMed ID: 11533530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEINS OF THE WHITE MATTER OF THE CEREBRAL HEMISPHERES (THE MEDULLARY VEINS).
    HUANG YP; WOLF BS
    Am J Roentgenol Radium Ther Nucl Med; 1964 Oct; 92():739-55. PubMed ID: 14215085
    [No Abstract]   [Full Text] [Related]  

  • 28. [PH determination in the brain and two-fold approach in the multiple-step cancer therapy concept. Possibilities of including the brain in the therapeutically tangible area of the body in multiple-step cancer therapy].
    von Ardenne M; Reitnauer PG
    Klin Wochenschr; 1970 Jun; 48(11):658-68. PubMed ID: 4325407
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular distribution of beta-trace protein in CNS and brain tumours.
    Olsson JE; Blomstrand C; Haglid KG
    J Neurol Neurosurg Psychiatry; 1974 Mar; 37(3):302-11. PubMed ID: 4208363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro action of lysine-vasopressin on the concentration of ribo- and deoxyribonucleic acids in malignant cerebral tumors. New perspectives on the host-tumor relationship in cancerology].
    Bernard-Weil E; Piette C; Olivier L; David M
    Ann Endocrinol (Paris); 1969; 30(3):399-403. PubMed ID: 4311599
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of fatty acid constituents in brain tumor tissue].
    Sato O; Sano K
    No To Shinkei; 1967 Dec; 19(12):1193-7. PubMed ID: 5630864
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression of Bcl2 proto-oncogene in primary tumors of the central nervous system.
    Tyagi D; Sharma BS; Gupta SK; Kaul D; Vasishta RK; Khosla VK
    Neurol India; 2002 Sep; 50(3):290-4. PubMed ID: 12391455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neutron activation analysis of the trace elements cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium in surgical specimens of human brain tumors. 1].
    Schicha H; Müller W; Kasperek K; Schröder R
    Beitr Pathol; 1974 Mar; 151(3):281-96. PubMed ID: 4365800
    [No Abstract]   [Full Text] [Related]  

  • 35. Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.
    Peredo I; Helldén A; Wolmer-Solberg N; Pohanka A; Stragliotto G; Rahbar A; Ståhle L; Bellander BM; Söderberg-Nauclér C
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26670887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
    Gajewicz W; Papierz W; Szymczak W; Goraj B
    Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain tumor microvesicles: insights into intercellular communication in the nervous system.
    van der Vos KE; Balaj L; Skog J; Breakefield XO
    Cell Mol Neurobiol; 2011 Aug; 31(6):949-59. PubMed ID: 21553248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy.
    Recht L; Torres CO; Smith TW; Raso V; Griffin TW
    J Neurosurg; 1990 Jun; 72(6):941-5. PubMed ID: 2159987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [POSSIBILITIES AND LIMITATIONS OF RADIOISOTOPES (CU-64 AND AS-74) IN THE DIAGNOSIS OF BRAIN TUMORS].
    WILCKE O
    Neurochirurgia (Stuttg); 1964 Feb; 7():33-41. PubMed ID: 14138671
    [No Abstract]   [Full Text] [Related]  

  • 40. ATPase in human brain tumors.
    Laws ER; O'Connor JS
    J Neurosurg; 1970 Aug; 33(2):167-71. PubMed ID: 4319012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.